Philadelphia Trust Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,592
Closed -$1.93M 236
2021
Q1
$1.93M Buy
+10,592
New +$2.46M 0.15% 98

Other funds holding TDOC

Philadelphia Trust Company's TDOC Position: Q2 2021 in Review

Philadelphia Trust Company sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 10,592 shares — an estimated $1.93M sold.

Philadelphia Trust Company first reported a position in TDOC in Q1 2021 and held it in 1 quarter. The position peaked at $1.93M in Q1 2021. 828 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Philadelphia Trust Company reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Philadelphia Trust Company sold 10,592 Teladoc Health shares in Q2 2021, an estimated $1.93M.
  • Philadelphia Trust Company first reported a position in Teladoc Health in Q1 2021 and held it in 1 quarter.
  • Philadelphia Trust Company's Teladoc Health position peaked at $1.93M in Q1 2021.
  • 828 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Philadelphia Trust Company's 13F filing for Q2 2021, filed 13 Aug 2021.